BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim H, Kim T, Kim M, Lee HY, Kim Y, Kang MS, Kim J. Activation of the alternative complement pathway predicts renal outcome in patients with lupus nephritis. Lupus 2020;29:862-71. [PMID: 32408850 DOI: 10.1177/0961203320925165] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Caza T, Wijewardena C, Al-rabadi L, Perl A. Cell Type-Specific Mechanistic Target of Rapamycin-Dependent Distortion of Autophagy Pathways in Lupus Nephritis. Translational Research 2022. [DOI: 10.1016/j.trsl.2022.03.004] [Reference Citation Analysis]
2 Koopman JJE, Rennke HG, McMahon GM, Waikar SS, Costenbader KH. Associations between renal deposits of complement factors, disease activity and loss of renal function in lupus nephritis. J Clin Pathol 2021:jclinpath-2021-207788. [PMID: 34969783 DOI: 10.1136/jclinpath-2021-207788] [Reference Citation Analysis]
3 Morell M, Pérez-Cózar F, Marañón C. Immune-Related Urine Biomarkers for the Diagnosis of Lupus Nephritis. Int J Mol Sci 2021;22:7143. [PMID: 34281193 DOI: 10.3390/ijms22137143] [Reference Citation Analysis]
4 Liu T, Yang M, Xia Y, Jiang C, Li C, Jiang Z, Wang X. Microarray-based analysis of renal complement components reveals a therapeutic target for lupus nephritis. Arthritis Res Ther 2021;23:223. [PMID: 34433493 DOI: 10.1186/s13075-021-02605-9] [Reference Citation Analysis]
5 Lu Q, Hou Q, Cao K, Sun X, Liang Y, Gu M, Xue X, Zhao AZ, Dai C. Complement factor B in high glucose-induced podocyte injury and diabetic kidney disease. JCI Insight 2021;6:e147716. [PMID: 34622800 DOI: 10.1172/jci.insight.147716] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Su B, Chen B, Lu G. Relationship of complement activation pathway to clinical and pathological characteristics and renal outcome in patients with lupus nephritis. Z Rheumatol 2021. [PMID: 34152436 DOI: 10.1007/s00393-021-00999-0] [Reference Citation Analysis]
7 Yang M, Yang B, Deng D. Targeting of EIF4EBP1 by miR-99a-3p affects the functions of B lymphocytes via autophagy and aggravates SLE disease progression. J Cell Mol Med 2021;25:10291-305. [PMID: 34668631 DOI: 10.1111/jcmm.16991] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Li NL, Birmingham DJ, Rovin BH. Expanding the Role of Complement Therapies: The Case for Lupus Nephritis. J Clin Med 2021;10:626. [PMID: 33562189 DOI: 10.3390/jcm10040626] [Cited by in F6Publishing: 1] [Reference Citation Analysis]